IL-23 modulated myelin-specific T cells induce EAE via an IFNγ driven, IL-17 independent pathway

Brain, Behavior, and Immunity

Volumn 25, Issue 5, 2011, Pages 932-937

  Kroenke, Mark A ^a,b   Segal, Benjamin M ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Autoimmune disease; Cytokines; Experimental autoimmune encephalomyelitis; Neuroinflammation; T helper cells

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR3; CXCL9 CHEMOKINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR BETA1; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 5 RECEPTOR ALPHA; INTERLEUKIN 6; INTERLEUKIN 9; MACROPHAGE DERIVED CHEMOKINE; MYELIN; RANTES; STEM CELL FACTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM; CYTOKINE PRODUCTION; EFFECTOR CELL; HISTOPATHOLOGY; IMMUNOMODULATION; INTERFERON PRODUCTION; MOUSE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH0 CELL; TH1 CELL; TH17 CELL;

ADOPTIVE TRANSFER; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-23; MICE; MICE, INBRED C57BL; RECEPTORS, INTERLEUKIN-17; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TH17 CELLS;

EID: 79957915063     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2010.10.001     Document Type: Article

References (40)

1. Ando D.G., Clayton J., Kono D., Urban J.L., Sercarz E.E. Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cell Immunol. 1989, 124:132-143.
2. Baron J.L., Madri J.A., Ruddle N.H., Hashim G., Janeway C.A. Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 1993, 177:57-68.
3. Beller D.I. Functional significance of the regulation of macrophage Ia expression. Eur. J. Immunol. 1984, 14:138-143.
4. Billiau A., Heremans H., Vandekerckhove F., Dijkmans R., Sobis H., Meulepas E., Carton H. Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma. J. Immunol. 1988, 140:1506-1510.
5. Chu C.Q., Wittmer S., Dalton D.K. Failure to suppress the expansion of the activated CD4 T cell population in interferon gamma-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J. Exp. Med. 2000, 192:123-128.
6. Correale J., Farez M. Association between parasite infection and immune responses in multiple sclerosis. Ann. Neurol. 2007, 61:97-108.
7. Cua D.J., Sherlock J., Chen Y., Murphy C.A., Joyce B., Seymour B., Lucian L., To W., Kwan S., Churakova T., Zurawski S., Wiekowski M., Lira S.A., Gorman D., Kastelein R.A., Sedgwick J.D. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003, 421:744-748.
8. Dasilva A.G., Yong V.W. Expression and regulation of matrix metalloproteinase-12 in experimental autoimmune encephalomyelitis and by bone marrow derived macrophages in vitro. J. Neuroimmunol. 2008, 199:24-34.
9. Duong T.T., St Louis J., Gilbert J.J., Finkelman F.D., Strejan G.H. Effect of anti-interferon-gamma and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse. J. Neuroimmunol. 1992, 36:105-115.
10. Duong T.T., Finkelman F.D., Singh B., Strejan G.H. Effect of anti-interferon-gamma monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains. J. Neuroimmunol. 1994, 53:101-107.
11. Ferber I.A., Brocke S., Taylor-Edwards C., Ridgway W., Dinisco C., Steinman L., Dalton D., Fathman C.G. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 1996, 156:5-7.
12. Fierz W., Endler B., Reske K., Wekerle H., Fontana A. Astrocytes as antigen-presenting cells. I. Induction of Ia antigen expression on astrocytes by T cells via immune interferon and its effect on antigen presentation. J. Immunol. 1985, 134:3785-3793.
13. Gocke A.R., Cravens P.D., Ben L.H., Hussain R.Z., Northrop S.C., Racke M.K., Lovett-Racke A.E. T-bet regulates the fate of Th1 and Th17 lymphocytes in autoimmunity. J. Immunol. 2007, 178:1341-1348.
14. Gruden-Movsesijan A., Ilic N., Mostarica-Stojkovic M., Stosic-Grujicic S., Milic M., Sofronic-Milosavljevic L. Trichinella spiralis: modulation of experimental autoimmune encephalomyelitis in DA rats. Exp. Parasitol. 2008, 118:641-647.
15. Haak S., Croxford A.L., Kreymborg K., Heppner F.L., Pouly S., Becher B., Waisman A. IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. J. Clin. Invest. 2009, 119:61-69.
16. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., Weaver C.T. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005, 6:1123-1132.
17. Hofstetter H.H., Forsthuber T.G. Kinetics of IL-17- and interferon-gamma-producing PLPp-specific CD4 T cells in EAE induced by coinjection of PLPp/IFA with pertussis toxin in SJL mice. Neurosci. Lett. 2010, 476:150-155.
18. Hofstetter H.H., Ibrahim S.M., Koczan D., Kruse N., Weishaupt A., Toyka K.V., Gold R. Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cell Immunol. 2005, 237:123-130.
19. Komiyama Y., Nakae S., Matsuki T., Nambu A., Ishigame H., Kakuta S., Sudo K., Iwakura Y. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 2006, 177:566-573.
20. Kroenke M.A., Segal B.M. Th17 and Th1 responses directed against the immunizing epitope, as opposed to secondary epitopes, dominate the autoimmune repertoire during relapses of experimental autoimmune encephalomyelitis. J. Neurosci. Res. 2007, 85:1685-1693.
21. Kroenke M.A., Carlson T.J., Andjelkovic A.V., Segal B.M. IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J. Exp. Med. 2008, 205:1535-1541.
22. Kroenke M.A., Chensue S.W., Segal B.M. EAE mediated by a non-IFN-gamma/non-IL-17 pathway. Eur. J. Immunol. 2010, 40:2340-2348.
23. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., McClanahan T., Kastelein R.A., Cua D.J. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 2005, 201:233-240.
24. McCarron R.M., Spatz M., Kempski O., Hogan R.N., Muehl L., McFarlin D.E. Interaction between myelin basic protein-sensitized T lymphocytes and murine cerebral vascular endothelial cells. J. Immunol. 1986, 137:3428-3435.
25. Momcilovic M., Miljkovic Z., Popadic D., Miljkovic D., Mostarica-Stojkovic M. Kinetics of IFN-gamma and IL-17 expression and production in active experimental autoimmune encephalomyelitis in Dark Agouti rats. Neurosci. Lett. 2008, 447:148-152.
26. Muller M., Carter S.L., Hofer M.J., Manders P., Getts D.R., Getts M.T., Dreykluft A., Lu B., Gerard C., King N.J., Campbell I.L. CXCR3 signaling reduces the severity of experimental autoimmune encephalomyelitis by controlling the parenchymal distribution of effector and regulatory T cells in the central nervous system. J. Immunol. 2007, 179:2774-2786.
27. Olsson T. Cytokines in neuroinflammatory disease: role of myelin autoreactive T cell production of interferon-gamma. J. Neuroimmunol. 1992, 40:211-218.
28. Oo Y.H., Weston C.J., Lalor P.F., Curbishley S.M., Withers D.R., Reynolds G.M., Shetty S., Harki J., Shaw J.C., Eksteen B., Hubscher S.G., Walker L.S., Adams D.H. Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver. J. Immunol. 2010, 184:2886-2898.
29. Oppmann B., Lesley R., Blom B., Timans J.C., Xu Y., Hunte B., Vega F., Yu N., Wang J., Singh K., Zonin F., Vaisberg E., Churakova T., Liu M., Gorman D., Wagner J., Zurawski S., Liu Y., Abrams J.S., Moore K.W., Rennick D., de Waal-Malefyt R., Hannum C., Bazan J.F., Kastelein R.A. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000, 13:715-725.
30. Refaeli Y., Van Parijs L., Alexander S.I., Abbas A.K. Interferon gamma is required for activation-induced death of T lymphocytes. J. Exp. Med. 2002, 196:999-1005.
31. Sabatino J.J., Shires J., Altman J.D., Ford M.L., Evavold B.D. Loss of IFN-gamma enables the expansion of autoreactive CD4+ T cells to induce experimental autoimmune encephalomyelitis by a nonencephalitogenic myelin variant antigen. J. Immunol. 2008, 180:4451-4457.
32. Sedgwick J.D., MacPhee I.A., Puklavec M. Isolation of encephalitogenic CD4+T cell clones in the rat. Cloning methodology and interferon-gamma secretion. J. Immunol. Methods 1989, 121:185-196.
33. Segal B.M., Shevach E.M. IL-12 unmasks latent autoimmune disease in resistant mice. J. Exp. Med. 1996, 184:771-775.
34. Segal B.M., Dwyer B.K., Shevach E.M. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J. Exp. Med. 1998, 187:537-546.
35. Sewell D., Qing Z., Reinke E., Elliot D., Weinstock J., Sandor M., Fabry Z. Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization. Int. Immunol. 2003, 15:59-69.
36. Sieve A.N., Meeks K.D., Lee S., Berg R.E. A novel immunoregulatory function for IL-23: Inhibition of IL-12-dependent IFN-gamma production. Eur. J. Immunol. 2010, 40:2236-2247.
37. Simmons R.D., Willenborg D.O. Direct injection of cytokines into the spinal cord causes autoimmune encephalomyelitis-like inflammation. J. Neurol. Sci. 1990, 100:37-42.
38. Vass K., Heininger K., Schafer B., Linington C., Lassmann H. Interferon-gamma potentiates antibody-mediated demyelination in vivo. Ann. Neurol. 1992, 32:198-206.
39. Willenborg D.O., Fordham S., Bernard C.C., Cowden W.B., Ramshaw I.A. IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 1996, 157:3223-3227.
40. Yang X.O., Pappu B.P., Nurieva R., Akimzhanov A., Kang H.S., Chung Y., Ma L., Shah B., Panopoulos A.D., Schluns K.S., Watowich S.S., Tian Q., Jetten A.M., Dong C. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 2008, 28:29-39.